Meta-Analysis of Randomized Trials of Intracoronary Versus Intravenous Glycoprotein IIb/IIIa Inhibitors in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Ayman Elbadawi(Ain Shams University), Jeremiah P. Depta(Rochester General Hospital), Islam Y. Elgendy(Harvard University), Erfan Alotaki(Rochester General Hospital), Le Dung Ha(Rochester General Hospital), Michael Megaly(St. John Medical Center), Marwan Saad(Ain Shams University), Ahmed Abuzaid(Alaska Heart and Vascular Institute), Gbolahan Ogunbayo(University of Kentucky), Karim Mahmoud(Houston Medical Center), Basarat Baig(Rochester General Hospital)
Cited by 23
Related Papers
Temporal Trends and Outcomes of Mechanical Complications in Patients With Acute Myocardial Infarction
|JACC: Cardiovascular Interventions|2019|374
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
|Journal of the American College of Cardiology|2025|346
Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale–Associated Stroke
|JAMA Neurology|2020|205
Aspirin for Primary Prevention of Cardiovascular Events
|Journal of the American College of Cardiology|2019|140
Burden of Ischemic and Hemorrhagic Stroke Across the US From 1990 to 2019
|JAMA Neurology|2024|115